Laura Hamill Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

YMAB Quotes by TradingView

Laura Hamill is Director of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 5,825 shares of YMAB, which is worth approximately $86,617. The most recent transaction as insider was on Jun 11, 2024, when has been sold 3,495 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.83K
0% 3M change
150.0% 12M change
Total Value Held $86,617

Laura Hamill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Grant, award, or other acquisition
-
3,495 Added 37.5%
5,825 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
2,330 Added 50.0%
2,330 Common Stock

Also insider at

JAZZ
Jazz Pharmaceuticals plc Healthcare
Director
ANAB
ANAPTYSBIO, INC Healthcare
Director
VCKA
Vickers Vantage Corp. I Financial Services
Director
PRDS
PARDES BIOSCIENCES, INC. Healthcare
Director
XLRN
ACCELERON PHARMA INC Healthcare
Director
LH

Laura Hamill

Director
New York, NY

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on YMAB